Drug intelligence / Profile preview

MEVAC Sheep Pox Vaccine

Development stage
Unknown
Lead developer
MEVAC
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

MEVAC Sheep Pox Vaccine is a veterinary live-attenuated vaccine developed by Middle East for Vaccines (MEVAC) for the active immunization of sheep against sheep pox. The vaccine is designed to induce a robust and protective immune response, including both humoral and cell-mediated immunity, against the Sheep Pox virus (a member of the Capripoxvirus genus). By presenting an attenuated form of the virus, the vaccine prepares the ruminant's immune system to recognize and neutralize the pathogen upon subsequent exposure, thereby preventing the development of clinical disease, skin lesions, and systemic complications. It is a critical tool for livestock health management in endemic regions, particularly across the Middle East and Africa.

Brand names
MEVAC Sheep Pox
Other names
Sheep Pox Vaccine (MEVAC)Sheep Pox (Ruminants) Vaccine

Beyond the preview

Go deeper on MEVAC Sheep Pox Vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEVAC Sheep Pox Vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call